The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Delusionality and Response to Open-Label Fluvoxamine in Body Dysmorphic Disorder
Open accessAbstract
BACKGROUND: Available data suggest that the delusional variant of body dysmorphic disorder (BDD), a type of delusional disorder, may respond to serotonin reuptake inhibitors (SRIs) and that delusionality (lack of insight) in BDD may improve with SRI treatment. However, this research has been hampered by the lack of a reliable and valid scale to assess delusionality. METHOD: Thirty subjects (21 women, 9 men; mean age = 33.3 +/- 9.0 years) with DSM-IV BDD were prospectively treated with open-label fluvoxamine for 16 weeks. Subjects were assessed at regular intervals with the Brown Assessment of Beliefs Scale (BABS), the Yale-Brown Obsessive Compulsive Scale Modified for BDD (BDD-YBOCS; a measure of BDD severity), and other instruments. The BABS is a reliable and valid 7-item, semistructured, clinician-administered scale that assesses current delusionality. RESULTS: In this prospective, open-label study, 63% of BDD subjects responded to fluvoxamine. Delusional and nondelusional subjects had similar improvement in BDD symptoms. In addition, insight significantly improved in both delusional and nondelusional subjects. Baseline BABS scores did not contribute significantly to endpoint BDD-YBOCS scores in a regression analysis. CONCLUSION: Degree of delusionality did not predict fluvoxamine response, and delusionality significantly improved. These findings are preliminary and require confirmation in controlled trials. The implications of these findings for other types of delusions requires investigation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
Prevalence and clinical characteristics of body dysmorphic disorder in an adult inpatient setting
Conroy, M., Menard, W., Fleming-Ives, K., Modha, P., Cerullo, H., & Phillips, K. A. (2008) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2007.09.004 · Cited by 144
Self-citation
Cited by
A Randomized Placebo-Controlled Trial of Fluoxetine in Body Dysmorphic Disorder
Phillips, K. A., Albertini, R. S., & Rasmussen, S. A. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.4.381 · Cited by 321
Self-citationInsight in obsessive compulsive disorder and body dysmorphic disorder
Eisen, J. L., Phillips, K. A., Coles, M. E., & Rasmussen, S. A. (2004) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2003.09.010 · Cited by 254
Self-citationPhillips, K. A., & Hollander, E. (2008) · Body Image · doi:10.1016/j.bodyim.2007.12.003 · Cited by 214
Self-citationMataix-Cols, D., Fernández de la Cruz, L., Isomura, K., Anson, M., Turner, C., Monzani, B., Cadman, J., Bowyer, L., Heyman, I., Veale, D., et al. (2015) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2015.08.011 · Cited by 110
Phillips, K. A., Keshaviah, A., Dougherty, D. D., Stout, R. L., Menard, W., & Wilhelm, S. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15091243 · Cited by 75
Self-citation
Metadata
- Authors
- Phillips, K. A., McElroy, S. L., Dwight, M. M., Eisen, J. L., & Rasmussen, S. A.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2001-02-15
- Volume
- 62
- Issue
- 2
- Pages
- 87-92
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2036087245
- Cited by
- 164
- References
- 2
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Delusionality and Response to Open-Label Fluvoxamine in Body Dysmorphic Disorder. https://app.cochat.ai/papers/10.4088/jcp.v62n0203
- The paper
- Phillips, K. A., McElroy, S. L., Dwight, M. M., Eisen, J. L., & Rasmussen, S. A. (2001). Delusionality and Response to Open-Label Fluvoxamine in Body Dysmorphic Disorder. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v62n0203
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.